FDA Approves New Emergency Contraceptive
Links shared publicly online about this topic.
- 927total visits
FDA Approves New Emergency Contraceptive
View full resource at healthbistro.lifescript.com
Tags: Emergency, Sex and Intimacy, FDA
Most Recently Shared on August 23, 2010 at 10:41 am By:
Bayer HealthCare receives FDA approval for Natazia to treat HMB
news-medical.net — “Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.” View full resource at news-medical.net
Most Recently Shared on March 15, 2012 at 4:43 am By:
Bayer HealthCare receives FDA approval for Natazia to treat HMB: Bayer HealthCare Pharmaceuticals Inc. today ann... http://t.co/owLKhz1u
NuPathe to resubmit migraine patch for approval in 2012
medcitynews.com — “NuPathe, an emerging biopharmaceutical company, received a complete response letter from the FDA. Read about what the company is doing to address it.” View full resource at medcitynews.com
Most Recently Shared on November 15, 2011 at 5:52 pm By:
NuPathe to resubmit migraine patch for approval in 2012: NuPathe (NASDAQ: PATH) said it will resubmit a new drug... http://t.co/GuXqAlQa
FDA Tentatively Approves Intelliject's Lead Product, E-cue™ - QualityPoint Technologies
qualitypointtech.net — “Intelliject, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the company's New Drug Application (NDA) for a novel epinephrine auto-injector, e-cue™, for emergency treatment of allergic reactions including anaphylaxis. The tentative approval of e-cue™ following a first cycle, 10-month review by the FDA provides validation of Intelliject's vision of developing patient-centric products and of the company's ability to execute...” View full resource at qualitypointtech.net
Most Recently Shared on August 6, 2011 at 2:45 pm By:
FDA Tentatively Approves Intelliject's Lead Product, E-cue™: Intelliject, Inc. announced that the U.S. Food and... http://bit.ly/p9t5lj
Feds Order Insurers To Cover Birth Control Free Of Charge To Women : Shots - Health Blog : NPR
npr.org — “Starting a year from now, most new health insurance policies will have to include a comprehensive list of women's preventive health services with no copay or deductible. Under the rule, insurers would have to cover all prescription contraceptives approved by the FDA.” View full resource at npr.org
Most Recently Shared on August 2, 2011 at 2:36 am By:
Feds Order Insurers To Cover Birth Control Free Of Charge To Women : Shots - Health Blog : NPR: http://t.co/QaqsMmR via @addthis
Feds Order Insurers To Cover Birth Control Free Of Charge To Women : Shots - Health Blog : NPR
npr.org — “Starting a year from now, most new health insurance policies will have to include a comprehensive list of women's preventive health services with no copay or deductible. Under the rule, insurers would have to cover all prescription contraceptives approved by the FDA.” View full resource at npr.org
Most Recently Shared on August 1, 2011 at 10:24 pm By:
Feds Order Insurers To Cover Birth Control Free Of Charge To Women: Starting a year from now, most new health insu... http://n.pr/nTFjQ9
Feds Order Insurers To Cover Birth Control Free Of Charge To Women : Shots - Health Blog : NPR
npr.org — “Starting a year from now, most new health insurance policies will have to include a comprehensive list of women's preventive health services with no copay or deductible. Under the rule, insurers would have to cover all prescription contraceptives approved by the FDA.” View full resource at npr.org
Most Recently Shared on August 1, 2011 at 5:45 pm By:
Feds Order Insurers To Cover Birth Control Free Of Charge To Women http://n.pr/pB6MJp
What's At Stake in How HHS Handles the IOM Report? | RH Reality Check
rhrealitycheck.org — “The recently announced recommendations of the Institute of Medicine (IOM) for those womenâ??s preventative health care services that must be provided, with no co-pays, by insurance plans under the new health care law have ignited the predictable firestorm. This is because one of the eight services recommended is coverage of all FDA-approved contraceptive methods. Professional medical organizations and health advoc” View full resource at rhrealitycheck.org
Most Recently Shared on July 29, 2011 at 4:31 pm By:
What's At Stake in How #HHS Handles the #IOM Report? http://bit.ly/oAxbCA #health #access #women #birthcontrol #fem2 #tpot
Insight into new drug resistance in hospital microbes
sciencedaily.com — “Hospitals struggle to prevent the infections that complicate treatment for cancer, joint replacement, heart surgery and other conditions. Hospital-acquired infections are often resistant to multiple antibiotics, leading to approximately 100,000 deaths and more than $30 billion in additional health care costs yearly. New drugs are being developed to combat these infections, but resistance invariably emerges to these last-line drugs. Daptomycin, a new antibiotic approved by the FDA in 2003, is” View full resource at sciencedaily.com
Most Recently Shared on July 14, 2011 at 3:42 pm By:
2 things really scare me in life:over-farming animals,and this: Insight into new drug resistance in hospital microbes: http://t.co/0h83PdE
Insight into new drug resistance in hospital microbes
sciencedaily.com — “Hospitals struggle to prevent the infections that complicate treatment for cancer, joint replacement, heart surgery and other conditions. Hospital-acquired infections are often resistant to multiple antibiotics, leading to approximately 100,000 deaths and more than $30 billion in additional health care costs yearly. New drugs are being developed to combat these infections, but resistance invariably emerges to these last-line drugs. Daptomycin, a new antibiotic approved by the FDA in 2003, is” View full resource at sciencedaily.com
Most Recently Shared on July 14, 2011 at 1:32 pm By:
FDA approves Matrix NDA for Zidovudine Tablets
news-medical.net — “Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration under the President's Emergency Plan for AIDS Relief for its New Drug Application for Zidovudine Tablets, 100 mg.” View full resource at news-medical.net
Most Recently Shared on March 11, 2011 at 7:22 am By:
HIV/AIDS News: FDA approves Matrix NDA for Zidovudine Tablets: Mylan Inc. today announced that its subsidiary Ma... http://bit.ly/eG4LYX
Medical News: FDA Approves Generic Birth Control Pill - in Product Alert, OTC from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a new generic oral contraceptive called Emoquette, a daily tablet that combines the hormonal compounds desogestrel and ethinyl estradiol to prevent pregnancy in wome” View full resource at medpagetoday.com
Most Recently Shared on March 5, 2011 at 4:01 pm By:
FDA Approves Generic Birth Control Pill: WASHINGTON (MedPage Today) -- The FDA has approved a… http://goo.gl/fb/AG2Et
Medical News: FDA Approves Generic Birth Control Pill - in Product Alert, OTC from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a new generic oral contraceptive called Emoquette, a daily tablet that combines the hormonal compounds desogestrel and ethinyl estradiol to prevent pregnancy in wome” View full resource at medpagetoday.com
Most Recently Shared on March 4, 2011 at 11:05 pm By:
Over-the-Counter Emergency Contraception? The FDA Saga Continues | RHRealityCheck.org
rhrealitycheck.org — “Are you tired of waiting for the FDA to get its head out of you-know-where and finally approve over-the-counter sales of emergency contraception? Then let them know.” View full resource at rhrealitycheck.org
Most Recently Shared on February 10, 2011 at 10:41 pm By:
Over-the-Counter Emergency Contraception? The #FDA Saga Continues http://bit.ly/dK6NFC #tlot @reprorights #HIV @reprodocs (TAKE ACTION)
FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA
news-medical.net — “Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Lamivudine and Zidovudine Tablets, 30 mg/60 mg.” View full resource at news-medical.net
Most Recently Shared on January 20, 2011 at 2:21 pm By:
HIV/AIDS News: FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA: Mylan In... http://bit.ly/dXASt0
U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels
medicalnewstoday.com — “Bayer HealthCare Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg” View full resource at medicalnewstoday.com
Most Recently Shared on December 17, 2010 at 3:31 pm By:
U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels: Bayer HealthCare Pharmaceutica... http://mnt.to/f/3Pfk
Advertisement

